GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (STU:RV6) » Definitions » Other Operating Expense

Charles River Laboratories International (STU:RV6) Other Operating Expense : €123 Mil (TTM As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Charles River Laboratories International Other Operating Expense?

Charles River Laboratories International's Other Operating Expense for the three months ended in Jun. 2024 was €30 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was €123 Mil.

Charles River Laboratories International's quarterly Other Operating Expense declined from Dec. 2023 (€31 Mil) to Mar. 2024 (€30 Mil) but then increased from Mar. 2024 (€30 Mil) to Jun. 2024 (€30 Mil).

Charles River Laboratories International's annual Other Operating Expense increased from Dec. 2021 (€110 Mil) to Dec. 2022 (€138 Mil) but then declined from Dec. 2022 (€138 Mil) to Dec. 2023 (€126 Mil).


Charles River Laboratories International Other Operating Expense Historical Data

The historical data trend for Charles River Laboratories International's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charles River Laboratories International Other Operating Expense Chart

Charles River Laboratories International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80.58 91.96 110.50 138.37 126.03

Charles River Laboratories International Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.64 32.07 31.20 29.97 29.98

Charles River Laboratories International Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €123 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Charles River Laboratories International Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Charles River Laboratories International Business Description

Traded in Other Exchanges
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Charles River Laboratories International Headlines

No Headlines